中恒集团：关于控股子公司获得药品注册证书的公告

Core Insights - Zhongheng Group announced the approval of two drugs by the National Medical Products Administration, indicating a positive development for the company's product portfolio [2] Drug Approval Details - The approved drugs include Nicardipine Tablets (specification: 5mg) and Ketorolac Tromethamine Injection (specification: 1ml: 30mg) [2]